B Myrvang
Publications by Year
Research Areas
Hepatitis C virus research, Leprosy Research and Treatment, Malaria Research and Control, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response(2007)208 cited
- Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.(1973)
- → Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop(2002)171 cited
- Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.(1971)
- → Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up(2002)129 cited
- → Age as a Risk Factor for Severe Manifestations and Fatal Outcome of Falciparum Malaria in European Patients: Observations from TropNetEurop and SIMPID Surveillance Data(2003)118 cited
- → Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy(2002)116 cited
- → Imported Schistosomiasis in Europe: Sentinel Surveillance Data from TropNetEurop(2006)94 cited
- → Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.(2004)90 cited
- → Raised serum ferritin predicts non‐response to interferon and ribavirin treatment in patients with chronic hepatitis C infection(2002)75 cited